QSS
SIOX

Quantitative Systematic Strategies’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Quantitative Systematic Strategies’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,591
Closed -$682K – 530
2016
Q2 		$682K Buy
+6,591
New +$659K 0.32% 152
2016
Q1 		– Sell
-1,949
Closed -$301K – 836
2015
Q4 		$301K Buy
+1,949
New +$254K 0.08% 775

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ZBI
Ziff Brothers Investments New York $267M AUM 49.36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantitative Systematic Strategies's SIOX Position: Q3 2016 in Review

Quantitative Systematic Strategies sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2016, closing a stake of 6,591 shares — an estimated $682K sold.

Quantitative Systematic Strategies first reported a position in SIOX in Q4 2015 and held it in 2 quarters. The position peaked at $682K in Q2 2016. 95 funds tracked by Wall St. Rank hold SIOX as of Q3 2016.

  • Quantitative Systematic Strategies reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 6,591 Sio Gene Therapies Inc. Common Stock shares in Q3 2016, an estimated $682K.
  • Quantitative Systematic Strategies first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Sio Gene Therapies Inc. Common Stock position peaked at $682K in Q2 2016.
  • 95 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2016, filed 17 Nov 2016.